Advanced Search
-
Publications
- All Publications
- Books
- Consensus Statements
- Economic Reports
- Environmental Scan
- Evidence Review
-
Health Technology Assessments /
Systematic Reviews - Health Topic Overviews / Scoping Reviews
- HTA Policy
- IHE Discussion Paper
- IHE Roundtable Report
- Journal Articles
- Methodology Papers
- Overview of Systematic Reviews
- Policy Report
- Rapid Reviews
- Statistics Handbooks
- Summary Reports
- News/Events
- General Content
- Adaptation
- Appropriate Use
- Benefits Design
- Cancer
- Cataracts
- Chronic Diseases / Disorders
- Community Health Centres
- Constraints
- COPD
- Core Data Set
- Cost-effectiveness analysis
- COVID-19
- Deliberative Processes
- Diabetes
- Diagnosis
- Diagnostic screening
- Diagonal approach
- Digital Health
- Economic Evaluation
- Effectiveness
- Emergency Care
- Endoscopy
- Epidemiology
- Epidural Steroid Injection
- Extreme Heat Events
- Fetal Alcohol Spectrum Disorder (FASD)
- Funding Models
- Genetic Testing
- Health Data
- Health Economics
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Health Topic Overviews
- Healthcare Services
- Heart Disease
- Heart Failure
- Immunology
- Infection control
- Infectious Diseases
- Innovation
- Life-Cycle
- Low-back pain
- Lumbar Spinal Fusion
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Opioid substance use disorder
- Orthopedic
- Other
- Pathology
- Pharmaceutical Policy
- Pharmaceuticals
- Policy Roundtable
- Precision Medicine
- Precision Oncology
- Prevention
- Primary Care
- Priority-Setting
- Psoriasis
- Public Health
- Quality Measures
- Quality of Life
- Radiofrequency Ablation
- Regulatory Approval
- Reimbursement
- Scoping Reviews
- Screening
- Spillover effects
- Surgery
- Surveillance
- Telehealth
- Therapy
- Uncertainty
- Urgent Care
- Vaccines
- Akpinar, Ilke
- Bond, Ken
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Guo, Bing
- Harback, Kate
- Institute of Health Economics, IHE
- Kirwin, Erin
- Lopatina, Elena
- McCabe, Christopher
- Moga, Carmen
- Palfrey, Dan
- Pollock, Michelle
- Rafferty, Ellen
- Razavilar, Negar
- Round, Jeff
- Seida, Jennifer
- Sproule, John
- Sutton, Andrew J.
- Tjosvold, Lisa
- Tran, Dat
- Warkentin, Lindsey
- Wright, Erica
- Yan, Charles
Vaccine development costs: a review
Abstract: The cost of drug development is commonly cited between US$800 and US$1.8 billion. A similar statistic for vaccines is yet to be estimated, and it is unclear whether the cost of vaccines is similar to drug development. Financial and regulatory policy significantly impacts the extent and cost of pharmaceutical development, and as such it is important that governments should be informed about the costs of developing vaccines. The purpose of this paper is to review the concept of drug and vaccine R&D costs, to review the associated literature and to relate these findings to the area of vaccine industry’s financial and regulatory policy.
Publication Type: Journal Articles
Year of Publication: 2013
Topics: Health Economics / Healthcare Costs, Pharmaceuticals
Authors: Arianna Waye, Philip Jacobs, Anthony Schryvers
ISSN: 1476-0584
Journal Title: Expert Review of Vaccines
Volume: 12
Issue: 12
Pages: 1495-1501